# EEG Biomarkers for ADHD Stimulant Treatment

> **NCT07650643** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Boston Children's Hospital** · enrollment: 220 (estimated)

## Conditions studied

- ADHD

## Interventions

- **DRUG:** methylphenidate HCl
- **DRUG:** Mixed amphetamine salts extended release

## Key facts

- **NCT ID:** NCT07650643
- **Lead sponsor:** Boston Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-15
- **Primary completion:** 2031-05-30
- **Final completion:** 2031-08-31
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2026-06-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07650643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07650643, "EEG Biomarkers for ADHD Stimulant Treatment". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07650643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*